Study: Effectiveness Gap Between Moderna’s COVID-19 Vaccine and Pfizer’s Widens Over Time

A new study seeking to shed light on real-world COVID-19 vaccine effectiveness shows a widening gap between Moderna’s and Pfizer’s vaccines four months after the second shot. Among the 3,600-plus U.S. adults without immunocompromising conditions who were enrolled in the study, vaccine effectiveness against COVID-19 hospitalization within the first four months of being fully inoculated was higher for the Moderna vaccine (93 percent) than the Pfizer-BioNTech vaccine (88 percent) and the J&J vaccine (71 percent), according to the Centers for Disease Control and Prevention (CDC). While the Moderna vaccine’s effectiveness dropped slightly to 92 percent after 120 days of full…